Phase Ib Clinical Trial of Vantictumab + Paclitaxel in Patients With Locally Advanced or Metastatic HER2− Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase Ib Clinical Trial of the Anti-Frizzled Antibody Vantictumab (OMP-18R5) Plus Paclitaxel in Patients With Locally Advanced or Metastatic HER2-Negative Breast Cancer
Breast Cancer Res Treat 2020 Nov 01;184(1)53-62, JR Diamond, C Becerra, D Richards, A Mita, C Osborne, J O'Shaughnessy, C Zhang, R Henner, AM Kapoun, L Xu, B Stagg, S Uttamsingh, RK Brachmann, A Farooki, M MitaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.